Abstract
A series of new 3-alkylcarbamoyl-1-aryl-3,5-dihydro-7,8-dimethoxy-4H-2,3-benzodiazepin-4-ones was synthesized starting from the corresponding 3-N-unsubstituted derivatives, previously described as noncompetitive AMPA-type glutamate receptor antagonists. The new compounds proved to protect against seizures induced by means of auditory stimulation in DBA/2 mice and some of them showed anticonvulsant properties comparable or better than those of GYKI 52466, the prototype of 2,3-benzodiazepine noncompetitive AMPA receptor antagonists.
Copyright 2004 Elsevier SAS
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Anxiety Agents / chemical synthesis*
-
Anti-Anxiety Agents / pharmacology
-
Anticonvulsants / chemical synthesis*
-
Anticonvulsants / pharmacology
-
Anticonvulsants / therapeutic use
-
Benzodiazepines / chemical synthesis*
-
Benzodiazepines / pharmacology
-
Benzodiazepines / therapeutic use
-
Mice
-
Mice, Inbred DBA
-
Receptors, AMPA / antagonists & inhibitors*
-
Seizures / drug therapy*
-
Seizures / prevention & control
-
Structure-Activity Relationship
Substances
-
Anti-Anxiety Agents
-
Anticonvulsants
-
Receptors, AMPA
-
GYKI 52466
-
Benzodiazepines